Stay updated on Tislelizumab & Sitravatinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner announces an NIH website transition and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.6%
    Check dated 2026-10-24T19:10:50.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site’s footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T21:48:32.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T22:00:39.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    A new revision entry (v3.7.0) has been added to the study record history, and the older revision (v3.6.6) has been removed from the list, updating the version history shown on the page.
    Difference
    0.1%
    Check dated 2026-09-19T20:34:28.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry: Revision: v3.6.6, replacing the previous Revision: v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T20:56:42.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page history shows a new site revision (v3.6.5) replacing v3.6.4, indicating a deployment update rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-08-08T17:29:24.000Z thumbnail image

Stay in the know with updates to Tislelizumab & Sitravatinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.